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NESorganizer of assembly of inﬂuenza virus, interacts with other virus components
and with cellular membranes. It has been proposed that M1 binding to lipids is mediated by its polybasic
region, but this could hitherto not been investigated in vivo since M1 accumulates in the nucleus of
transfected cells. We have equipped M1 with nuclear export signals and showed that the constructs are
bound to cellular membranes. Exchange of the complete polybasic region and of further hydrophobic amino
acids in its vicinity did not prevent association of M1 with membranes. We therefore suppose that M1
probably interacts with membranes via multiple binding sites.
© 2008 Elsevier Inc. All rights reserved.Introduction
The matrix protein M1 forms a proteinaceous layer underneath
the envelope in inﬂuenza virus particles. M1 interacts with the
glycoproteins hemagglutinin (HA) and neuraminidase (NA) and with
the ribonucleotide particles (RNP) containing the viral genome not
only in the virus particle, but also during assembly and budding in
the infected cell. Therefore, M1 is considered the key organizer of
virus assembly. Furthermore, M1 has an intrinsic lipid-binding
activity which targets the protein to cellular membranes (Boulo
et al., 2007; Chen and Lamb, 2008; Nayak et al., 2004; Schmitt and
Lamb, 2005).
Crystallography of the N-terminal two-thirds of M1 revealed a
brick-shaped, helical structure (Arzt et al., 2001, 2004; Harris et al.,
2001; Sha and Luo, 1997); helix six of M1 contains a prominent stretch
of basic amino acids encompassing residues 95–105 (colored red and
orange in Fig. 1A), which is exposed at the surface of the molecule.
Removal of the complete polybasic region is lethal for virus replication
(Burleigh et al., 2005; Liu and Ye, 2002), and substitution of only two
residues led to severe replication defects in recombinant virus (Liu
and Ye, 2004, 2005). On amolecular level the polybasic region serves a
multitude of functions which are required at several stages of thel rights reserved.complex life cycle of the protein. The stretch 101-RKLKR-105 (red in
Fig. 1A) is a nuclear localization signal (NLS) that targets newly
synthesizedM1 to the nucleus (Ye et al., 1995,1989). In the nucleusM1
binds, probably via its C-terminal domain, to RNPs and via the
polybasic region to NS2 (Akarsu et al., 2003), a viral protein that
mediates nuclear export of the resulting NS2-M1-RNP complexes. The
polybasic region might also support oligomerization of M1 (Arzt et al.,
2001; Baudin et al., 2001; Noton et al., 2007) and is apparently
involved in budding of virus particles, since the virion morphology is
altered upon single amino acid mutations (Burleigh et al., 2005). In
addition, it has been suggested from liposome-binding experiments
that the polybasic region is essential for membrane binding of M1,
probably by mediating interactions with negatively charged phos-
pholipids (Baudin et al., 2001; Ruigrok et al., 2000), but this was never
tested experimentally inside the cells. The hypothesis that the
membrane binding of M1 is mediated by its polybasic region is not
easily amenable to experimental approaches because M1 has to be
expressed in the absence of other viral components to exclude that
anymembrane binding ismediated by those components. However, in
that case M1 accumulates in the nucleus of transfected cells (Latham
and Galarza, 2001; Sato et al., 2003) (see also Fig. 1B), which greatly
reduces the proportion of membrane-associated protein. Further-
more, removal of the NLS to circumvent nuclear transport would
disrupt the proposed membrane binding signal. For that reason we
sought for other means of enriching M1 at cellular membranes in
Fig. 1. Localization ofM1 constructs in transfected CHO-K1 cells (A). Molecular surface of
the N-terminal domain of M1 (PDB: 1EA3, (Arzt et al., 2001)) with the basic amino acids
in the polybasic region highlighted in orange and red, the latter representing the nuclear
localization signal (NLS, residues 101, 102, 104, 105). Additional putatively interactive
amino acids present on both sides of the polybasic region are highlighted in green and
blue. The representationswere created using PyMOL and rotated by 30°. (B–E) Localization
of M1 (immunoﬂuorescence with anti-fowl plague virus antiserum), YFP-M1, Myr-M1-
YFP and YFP-M1-NES in transfected CHO-K1 cells analyzed by confocal microscopy.
Images are pseudocolored green. (F, G) Colocalization of YFP-M1-wt (F) and YFP-M1-NES
(G) (pseudocolored green) with organelle markers (immunoﬂuorescence, pseudocolored
red) for the endoplasmic reticulum (ER, anti-calreticulin antibody) and the Golgi
apparatus (anti-membrin antibody) as indicated. Colocalization is shown in the merged
images and the enlargement of the respective boxed areas below. Scale bar, 10 μm.
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directed mutagenesis.
Results and discussion
We ﬁrst expressed authentic M1 from Inﬂuenza A/FPV/Rostock/34
and M1 fused to the yellow-ﬂuorescent protein (YFP) in CHO-K1 cells.
As expected, M1 was detected mainly in the nucleus of transfected
cells (Figs. 1B, C); but only M1-YFP was expressed to amounts thatcould be demonstrated by Western blotting (see Fig. 3A and data not
shown).
We then employed two strategies to achieve exclusion of M1-YFP
from the nucleus. Since it has been described that attachment of short
peptides encoding acylation signals leads to elimination of nuclear
transport (McCabe and Berthiaume, 1999), we modiﬁed M1-YFP with
an N-terminal myristoylation signal (amino acid sequence: MGSIKSK)
yielding the construct Myr-M1-YFP. Since myristate itself is not
hydrophobic enough to confer permanent anchoring to membranes,
stable binding to lipids is mediated by othermeans, such as a cluster of
basic amino acids (Resh, 2006). As a second strategy, we attempted to
induce export of M1 out of the nucleus. Co-expression of NS2, its
natural carrier for nuclear export, is not a reasonable approach, since
this protein binds to the polybasic region and thus masks the putative
membrane binding signal. We therefore fused the nuclear export
signal (NES) derived from the Rev protein of human immunodeﬁciency
virus (Pollard and Malim, 1998) (amino acid sequence: LQLPPLERLTL)
to the C-terminus of M1 yielding the construct YFP-M1-NES. After
transfection of CHO-K1 cells with the respective plasmids, confocal
microscopy showed that both proteins are excluded from the nucleus
in most cells (Figs. 1D, E). However, Myr-M1-YFP was very poorly
expressed (see Western blot in Fig. 3A, ﬁrst lane). Therefore, the
subsequent analyses could only be performed with YFP-M1-NES.
We veriﬁed the functionality of the NES by applying Leptomycin B
(LMB), a drug which blocks Crm1-dependent nuclear export (Fukuda
et al., 1997; Kudo et al., 1998) and which was shown to impede the
nuclear export of HIV Rev, the source of the NES applied here (Wolff
et al., 1997). One hundred cells expressing M1-YFP-NES, either treated
or not treated with LMB, were examined by ﬂuorescence microscopy
whetherM1-YFP-NES localizesmainly inside or outside of the nucleus.
Upon treatment with LMB, the percentage of cells showing distinct
nuclear localization of YFP-M1-NES was augmented from 13% to 53%;
concomitantly, the proportion of cells showing clear nuclear exclusion
of ﬂuorescence was decreased from 54% to 13%. The remaining cells
(33% and 34%, respectively) showed approximately equal ﬂuorescence
inside and outside of the nucleus (Fig. 2). This result indicates that the
majority of YFP-M1-NES molecules are initially transported into the
nucleus before NES-mediated nuclear export occurs and that addition
of NES shifted the dynamic equilibrium between nuclear and cytosolic
M1 subpopulations towards the latter.
Authentic M1 expressed in the absence of other viral proteins is
targeted to the endoplasmic reticulum (ER) and the Golgi (Ali et al.,
2000). We therefore analyzed the subcellular localization of our M1
constructs by confocal microscopy using marker antibodies for
intracellular membranes in order to check for accurate intracellular
targeting. When YFP-M1was examined (Fig. 1F), we observed, besides
cytoplasmic staining, limited colocalization with the ER and conside-
rable colocalization with the Golgi, which is illustrated as yellow
pixels in the merged image. The enlargement of a representative area
further clariﬁes that most of the Golgi area, but only some regions of
the ER colocalize with YFP-M1. Likewise, a similar subcellular
distribution of ﬂuorescence and a similar colocalization pattern with
ER and Golgi was observed for YFP-M1-NES (Fig. 1G). Taken together,
our data demonstrate that the subcellular targeting is not compro-
mised in our M1 constructs as compared to untagged M1—the
addition of YFP did not result in altered subcellular localization, and
the introduction of the NES did not change any targeting features
except nuclear localization. However, we do not know whether YFP-
M1-NES can replace authentic M1 in all of its functions, i.e.whether it
shows the (proposed) binding to HA and NA to enhance their intrinsic
budding activity (Chen et al., 2007) or whether it can bind to vRNPs.
The latter activity is probably compromised since the amount of M1 in
the nucleus is reduced. However, we concluded from our data that
YFP-M1-NES is an appropriate probe to study its intracellular
trafﬁcking and its interaction with membranes, since it behaves in
all of these aspects like authentic M1.
Fig. 2. Blocking nuclear export of YFP-M1-NES with Leptomycin B (LMB) CHO-K1 cells
transfected with YFP-M1-NES were left untreated (left picture) or treated with LMB
(right picture) as described inMaterial andmethods. The bars next to the representative
microscopic images show the distribution of YFP ﬂuorescence in 100 cells examined
visually by ﬂuorescence microscopy. White: indicates mainly cytosolic localisation of
M1, such as two cells in the left ﬁgure; gray: equal distribution of M1 throughout
cytoplasm and nucleus as in the case of the cell marked with an asterisk in the left
ﬁgure; black: mainly nuclear localisation of M1 as apparent from the right picture.
Fig. 3. Expression and localization of M1 mutants. (A) Expression of Myr-M1-YFP and
YFP-M1-NES including the indicated mutants thereof in transfected CHO-K1 cells. The
lysate of approximately 20,000 cells was subjected to SDS-PAGE and Western blot with
an anti-fowl plague virus antiserum. The mobility of molecular mass marker is depicted
on the left. (B) Immunoﬂuorescence of CHO-K1 cells transfected with YFP-M1-NES and
mutants thereof as indicated in Fig. 3A using anti-fowl plague virus antiserum.
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association of M1, we replaced the six arginines and lysines between
residue 95 and 105 of M1 by alanines in YFP-M1-NES. Western blot
analysis revealed that the polybasic mutant was expressed in similar
amounts and with the same molecular mass as the corresponding
wildtype protein (Fig. 3A, compare lane 2 with lane 1). The mutant
also showed comparable subcellular localization as non-mutated YFP-
M1-NES (Fig. 3B, compare picture 2 with picture 1).
We then assessed the membrane binding of M1 biochemically
since this question cannot be clariﬁed microscopically. Upon ultra-
centrifugation of a post-nuclear supernatant of cell homogenates at
100,000×g, YFP-M1-NES was predominantly found in the pellet,
indicating partial membrane association (Fig. 4A, panel 1), which is in
line with previous studies (Baudin et al., 2001; Kretzschmar et al.,
1996; Zhang and Lamb,1996). However, also the polybasic mutantwas
found in the 100,000×g pellet (Fig. 4A, panel 2), which implies that its
membrane association properties are not eliminated.
To mediate lipid-binding of peripheral membrane proteins, basic
amino acids work often in concert with neighboring hydrophobic
residues (Mulgrew-Nesbitt et al., 2006), especially with tyrosine and
leucine, which are large enough to insert into the bilayer (Wimley and
White, 1996). The crystal structure of M1 shows that Y100 and L130
(green in Fig.1A) extend the polybasic region on one side and L117 and
Y119 (blue in Fig. 1A) on the other side. These residues were replaced,
individually or in combination, by alanines in the polybasicmutant. All
M1-mutants were expressed to similar levels in transfected cells
(Fig. 3A, lanes 3–6); also their subcellular localization was similar
(Fig. 3B, images 3–6). They were all found primarily in the 100,000×g
pellet (Fig. 4A, panels 3–6; data quantiﬁed in Fig. 4C), indicating that
they still exert membrane binding.
Although it is known that replacement of the polybasic region by
alanines does not change the overall structure of the M1-protein
(Arzt et al., 2004), we performed a membrane ﬂoatation assay to
exclude that the 100,000×g pellet is composed of precipitated
protein. Membranes and associated integral proteins ﬂoat up to
their buoyant density and are found exclusively in the top fraction as
exempliﬁed in Fig. 4B for the integral membrane protein hemagglu-
tinin (HA) fused at its cytoplasmic tail to YFP. In contrast, soluble
proteins (and protein aggregates not bound to membranes) com-
pletely remain on the bottom of the gradient as shown here for
expressed YFP (Fig. 4B). When YFP-M1-NES was analyzed, a
signiﬁcant fraction ﬂoated up with the membranes, but
another portion remained on the bottom of the gradient (Fig. 4B,
panel 1) conﬁrming that the protein is partially membrane-bound
(Kretzschmar et al., 1996; Zhang and Lamb, 1996). In contrast to HA-YFP, M1-YFP-NES is present throughout the gradient, probably
because the membrane binding of M1, which lacks a transmembrane
domain, is not stable, but a transient and dynamic event. When all
the M1-YFP-mutants were analyzed (Fig. 4B, panels 2–6; quantiﬁca-
tion in Fig. 4D), a similar membrane fractionation pattern as for the
corresponding wildtype protein was observed, which conﬁrms the
results from the 100,000×g assay. Quantiﬁcation of Western blots
revealed slight differences in the extent of membrane association of
certain M1-mutants when the membrane-pelleting and membrane-
ﬂoatation assays were applied (compare Figs. 4C, D). However, it is
evident that neither method yielded a reduction in membrane
attachment for any of the mutants. Furthermore, it can even be
inferred that the membrane binding capacity of the mutants is
increased since the ratio between the 100,000×g pellet and super-
natant signal is higher and since relatively more protein is present in
fractions a to c compared to YFP-M1-NES in the ﬂoatation assay. We
suspect that removal of the NLS in the polybasic mutants blocks
nuclear import of M1-YFP-NES and thus more M1 is available in the
cytosol to bind to membranes.
In summary and in contrast to the suggestion from in vitro studies
(Baudin et al., 2001; Ruigrok et al., 2000), we do not observe an
exclusive role of the polybasic region in membrane association in vivo.
Our biochemical assays show that neither replacement of the
polybasic region nor exchange of additional amino acids in its vicinity
abolishes membrane association of YFP-M1-NES. Likewise, the
intracellular distribution of ﬂuorescence as assessed by confocal
microscopy (Fig. 3B) was not markedly changed in the mutants as
compared to non-mutated YFP-M1-NES; it appears that the mutants
were not redistributed to e. g. the plasma membrane. Our results do
not exclude that the polybasic region and its surroundings are
involved in interactions with lipids, but they are certainly not the
sole determinant for membrane association of M1. This is supported
by tritium-bombardment of virus particles (Shishkov et al., 1999) and
mass-spectrometric analysis of in-situ Bromelain-treated M1
Fig. 4. Biochemical analysis of M1membrane association. (A) Separation of membranes (pellet, P) and cytosol (supernatant, S) by ultracentrifugation of a post-nuclear supernatant at
100,000×g. YFP-M1-NES and mutants thereof (1–6) as depicted in Fig. 3A. A Western blot using anti-fowl plague virus antiserum is shown. HA-YFP: transmembrane protein
hemagglutinin fused to YFP as positive control for membrane binding, YFP: cytosolic YFP used as negative control. HA-YFP and YFP were detected with an anti-GFP antibody. (B)
Floatation of a post-nuclear supernatant prepared from transfected cells in a Nycodenz gradient. a–d: fractions from top to bottom of the gradient. Membranes ﬂoat to the top of the
gradient (fraction a) as demonstrated by the integral membrane protein HA fused to YFP, whereas soluble proteins remain on the bottom of the gradient in fraction d as shown for YFP.
M1 Samples are designated as in Fig. 4A. (C, D) Quantiﬁcation of data from triplicate experiments as conducted in Figs. 4A and B, respectively. The integrated densities of the bands
were measured using ImageJ and normalized. Gray bars indicate the proportion of membrane-associated protein (100,000×g pellet and fractions a–c, respectively). Error bars:
standard error of the mean (SEM).
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including the polybasic region, but also the C-terminal domain, are in
close proximity to the viral membrane.
To summarize, our data for various mutants of M1, together with
previous ﬁndings, lead to the assumption that several different
regions of M1 mediate membrane association synergistically by
means of a multitude of weak interactions that, in combination, lead
to a strong interaction force. One of these regions on its ownmight not
be sufﬁcient to sustain membrane binding, and the abolition of one of
these regions might hence not eliminate membrane association of the
complete protein. This cooperativity effect has the advantage that
individual interactions might be replaced by others without detaching
the protein from the membrane. The presumed versatility of its
interaction surface might be required for M1 to travel via vesicular
carriers from the ER to microdomains of the plasma membrane. Since
the membranes along the exocytic pathway have a very different
composition (van Meer et al., 2008), M1 probably interacts with
various lipids. Furthermore, some interactions of M1 with lipids must
be replaced by interactions with the cytoplasmic tails of HA and NA to
integrate the glycoproteins into budding virus particles. Strong
membrane binding via one single domain would not enable M1 to




The M1 open reading frame from Inﬂuenza A/FPV/Rostock/34 was
ampliﬁed from pHH-M by polymerase-chain reaction (PCR) andsubcloned into pEYFP-N1 (Clontech) using the restriction endonu-
cleases XhoI and SacII, yielding M1 with an N-terminal YFP tag (YFP-
M1), and into pEYFP-C1 with XhoI and KpnI (M1-YFP). The plasmid
encoding M1 without any tag was generated by replacement of the
YFP open reading frame in pEYFP-N1 by the M1 ORF with
polyadenylation signal from the M1-YFP expression vector using
XhoI and AﬂII. The modiﬁcation of YFP-tagged M1 with an N-terminal
myristoylation signal (amino acids MGSIKSK) and a C-terminal
nuclear export signal (NES, amino acids LQLPPLERLTL, derived from
HIV-1 Rev protein) was introduced by PCR with primers encoding the
additional amino acids. For the construction of Myr-M1-YFP, the PCR
product was subcloned into pEYFP-C1 with XhoI and SacII; YFP-M1-
NES was constructed by subcloning the PCR product into pEYFP-N1
using XhoI and KpnI. Site-directed mutagenesis was performed on
YFP-M1-NES by overlap-extension PCR. The accuracy of each
construct was tested by sequencing.
Cell culture and transfection
CHO-K1 cells (ATCC CCL61) were cultured in DMEM supplemented
with 10% fetal calf serum and maintained at 37 °C, 5% CO2, 95%
humidity. Cells were seeded into 35 mm dishes (for membrane
binding assays) or onto coverslips in 24-well plates (for immuno-
ﬂuorescence and microscopy). Cells were transfected using Lipofecta-
mine 2000 (Invitrogen) according to the manufacturer's instructions.
Leptomycin B treatment
To assess nuclear export, the inhibitor Leptomycin B (LMB,
obtained from Alexis Biochemicals, solubilized in ethanol) was
154 B. Thaa et al. / Virology 383 (2009) 150–155added to the cells 24 h after transfection at a ﬁnal concentration of
10 ng/mL in DMEM. After 60 min of incubation, cells were ﬁxed as
described below. The subcellular localization of ﬂuorescence was
determined microscopically by randomly choosing ﬁelds and analyz-
ing a total number of 100 cells for either predominantly nuclear or
predominantly cytoplasmic or equally distributed ﬂuorescence.
Membrane binding assays
To assess the membrane association of M1 biochemically, cells were
harvested 24 h after transfection, washed with phosphate-buffered
saline (PBS), incubated for 60 min in hypotonic buffer (1 mM Tris–HCl
pH7.4, 0.1mMMgCl2) on ice, homogenized on ice by 100 strokeswith a
Dounce homogenizer. The homogenatewas cleared of nuclei and debris
by low-speed centrifugation (1000×g, 10 min, 4 °C), and the post-
nuclear supernatant was subjected to ultracentrifugation (100,000×g,
4 °C, 60min) in a TLA-100.2 rotor (Beckman). The pellet (containing the
membranes) was resuspended in SDS-PAGE loading buffer, the super-
natant (cytosol) was subjected to protein precipitation with trichlor-
oacetic acid (TCA, 10% ﬁnal concentration). The samples were subjected
to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and analyzed by Western blot using a rabbit-anti-fowl plague
virus antiserum or a rabbit-anti-GFP antibody (Invitrogen) and a
horseradish-peroxidase-conjugated anti-rabbit secondary antibody.
Chemiluminescence was detected using ECL plus (GE Healthcare).
To perform the membrane ﬂoatation assay, the post-nuclear super-
natant (see above) was mixed with 3 vol of 105% (w/v) Nycodenz in
gradient buffer (20 mM Tris–HCl pH 7.5, 100 mM NaCl, 1 mM EDTA),
placed on the bottom of an ultracentrifuge tube, overlaid with 61/2 vol of
58% Nycodenz and 21/2 vol of 8% Nycodenz and subjected to
ultracentrifugation (100,000×g at 4 °C for 16 h). The gradient was divided
into four aliquots of equal size (a–d from top to bottom). Protein was
precipitated using TCA and subjected to SDS-PAGE and Western blot.
For quantitative analysis of Western blots, ﬁlms were scanned,
saved as TIFF ﬁles and analyzed bymeasuring the integrated density of
each band with ImageJ.
Immunoﬂuorescence and confocal microscopy
The ER and the Golgi apparatus were stained using indirect
immunoﬂuorescence. Cells grown on coverslips were ﬁxed 24 h after
transfection with 3% (w/v) paraformaldehyde in PBS for 10 min,
followed by permeabilization with 0.5% (v/v) Triton X-100 in PBS for
3 min. Epitopes were blocked by applying blocking solution (3% (w/v)
bovine serum albumin in PBS) for 60 min. The coverslips were then
incubated with primary antibody diluted in blocking solution for
60 min. The following antibodies were used: rabbit-anti-calreticulin
(Calbiochem) at a dilution of 1:200 as amarker for the ER,mouse-anti-
membrin (Abcam,1:500) to stain the Golgi apparatus, or a rabbit-anti-
fowl plague virus antiserum (1:250). Coverslips were washed three
times with PBS between each step. The coverslips were then treated
with an Alexa568-conjugated anti-mouse or anti-rabbit secondary
antibody (Molecular Probes, 1:1000) for 60 min and mounted onto a
microscope slide.
Microscopy was conducted with a Leica TCS SP2 confocal laser-
scanning microscope. The ﬂuorescence of YFP was excited at 514 nm
with an argon laser and recorded between 528 and 550 nm
(pseudocolored green); the excitation of Alexa568 ﬂuorescence was
at 543 nmwith a HeNe laser, the emission was recorded between 580
and 664 nm (pseudocolored red). Images were processed using Adobe
Photoshop.
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